C17ORF63-GYS2 Fusion FISH Probe
The C17ORF63-GYS2 Fusion FISH Probe is used to confirm a fusion of the C17ORF63 and GYS2 genes. The fusion of the C17ORF63 and GYS2 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| C17ORF63-GYS2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| C17ORF63-GYS2-20-AQAQ | 20 (40 μL) | 200 μL |
|
GYS2 Gene Summary
The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
Gene Name: Glycogen Synthase 2
Chromosome: CHR12: 21689122 -21757781
Locus: 12p12.1
Gene Diseases
The C17ORF63 GYS2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|